We earn commissions from brands listed on this site, which influences how listings are presented. Advertising Disclosure

Get Thin MD

Get Thin MD vs Embody Sermorelin Comparison

Side-by-side comparison of pricing, physician credentials, pharmacy standards, and lab monitoring protocols.

Embody
Get Thin MD

Get Thin MD

9.2 Very GoodVisit Get Thin MD
Embody

Embody

9.8 OutstandingVisit Embody
CriteriaGet Thin MDEmbody
Starting Price$119/mo$99/mo
Our Score9.2 Very Good9.8 Outstanding
Best ForSermorelin paired with medical weight loss protocolsSermorelin and bioidentical hormone therapy for women's health optimization
BadgeEditor's Pick
No Insurance NeededBioidentical HRT
Fully OnlineNo Insurance Needed
Progress TrackingFully Online

Get Thin MD

Sermorelin paired with medical weight loss protocols

Pros

  • Weight loss and sermorelin protocols integrated
  • Dedicated patient portal for progress tracking
  • Accessible pricing for combination programs
  • Experienced medical staff in weight and hormone medicine

Cons

  • Less clinical depth for pure hormone optimization
  • Lab monitoring fees not included in base plan
Visit Get Thin MD

Embody

Sermorelin and bioidentical hormone therapy for women's health optimization

Pros

  • Specialist focus on female hormone optimization
  • Sermorelin combined with bioidentical HRT options
  • Full female hormone panel at intake
  • Providers experienced in perimenopause and menopause protocols

Cons

  • Protocol design takes longer due to comprehensive female hormone evaluation
  • Limited availability in some states
Visit Embody

Overview

Get Thin MD[1] offers injectable sermorelin with an oral dropper option, nationwide, and shows pricing after its intake quiz[1]. Embody[2] charges from $99 per month for either a weekly injection or daily tablet, with no bloodwork required[2]. Both are accessible programs; delivery options and lab approach are the main contrasts.

At a Glance

MetricGet Thin MDEmbody
Starting priceShown after quizFrom $99/mo
Delivery formInjectable + oral dropperWeekly injection + daily tablet
Lab testing requiredMay be ordered (provider discretion)No bloodwork required
GuaranteeOptional lab evaluation100% refundable if not eligible
Platform focusWeight loss / anti-agingConsumer wellness

Key Differences

Price and delivery options

Embody publishes from $99 per month for both a weekly injection and a daily tablet[2]. Get Thin MD offers injectable sermorelin with an oral dropper option, with pricing shown after its quiz[1]. Both offer a non-injection option, and Embody offers transparent low-cost pricing.

Lab evaluation stance

Get Thin MD states laboratory testing may be ordered to assess baseline hormone levels[1]. Embody requires no bloodwork to begin[2]. Patients who want a baseline IGF-1[3] reading can arrange one at either; Get Thin MD references lab evaluation more directly.

Consumer protections

Embody offers a 100% refund if not eligible, cancel-anytime, and no hidden fees or price increases[2]. Get Thin MD provides accurate regulatory context and the option to transfer an existing protocol[1] but does not publish equivalent refund language. Embody's consumer protections are more explicit.

In Depth

Pricing and delivery

Embody publishes from $99 per month for both a weekly injection and a daily tablet, with cancel-anytime[2]. Get Thin MD shows pricing after its intake quiz and offers an injectable with an oral dropper option[1]. Both offer a non-injection option, and Embody offers transparent low-cost pricing.

Lab evaluation vs. no-bloodwork intake

Get Thin MD states laboratory testing may be ordered to assess baseline hormone levels[1]. Embody requires no bloodwork to begin[2]. Neither publishes batch-level COA documentation; patients who want a baseline IGF-1[3] can arrange one at either.

Consumer protections and accessibility

Embody offers a 100% refund if not eligible, with a 4.8 rating from 125,000+ customers[2]. Get Thin MD provides accurate regulatory context and the option to transfer an existing protocol[1]. Embody is the more consumer-accessible model; Get Thin MD provides clearer clinical framing.

Clinical framing and platform scope

Get Thin MD frames sermorelin around fat metabolism and weight management alongside GLP-1 and NAD+ treatments[1]. Embody frames sermorelin as a GHRH analog within a consumer wellness platform[2]. Both target body composition through GH axis restoration.

Bottom line

Embody wins on price, delivery-form choice, and consumer protections. Get Thin MD wins on lab-evaluation framing and regulatory context. The choice depends on whether cost and flexibility or clinical framing is the higher priority.

Frequently Asked Questions

How does pricing compare between Get Thin MD and Embody?

Embody publishes from $99 per month with cancel-anytime[2]. Get Thin MD shows pricing after its intake quiz[1]. Embody is the lower-cost, more transparent option.

Does Get Thin MD offer a tablet like Embody?

Get Thin MD offers injectable sermorelin with an oral dropper option[1]. Embody offers a weekly injection and a daily tablet[2].

Which is better for weight management?

Get Thin MD frames sermorelin around fat metabolism and weight management[1]. Embody is a consumer wellness platform[2]. Get Thin MD provides more explicit weight-management framing.

What consumer protections does Embody offer?

Embody offers a 100% refund if not eligible, cancel-anytime, and no price increases[2]. Get Thin MD provides optional lab evaluation and protocol transfer[1].

References

  1. Get Thin MD Sermorelin Peptide Therapy: product page (mechanism, regulatory history, online consultation, optional lab work, nationwide availability) getthinusa.com, 2026. https://www.getthinusa.com/muscle-growth/sermorelin
  2. Embody Sermorelin Therapy: product page (from $99/month, no insurance or bloodwork required, licensed U.S. pharmacy, weekly injection and daily tablet forms, cancel anytime) sermorelin.joinem.co, 2026. https://sermorelin.joinem.co/
  3. Khorram O, Laughlin GA, Yen SS Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women J Clin Endocrinol Metab, 1997. PMID 9141536. https://pubmed.ncbi.nlm.nih.gov/9141536/